Pharmaceutical

FDA approves Astellas’ VYLOY for gastric cancer treatment

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.

Oct 22, 2024 - 04:00
FDA approves Astellas’ VYLOY for gastric cancer treatment
Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced gastric cancer.
Read the original article

Tags:

Previous Article

FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Super DC Vaccine by Shanghai Cell Therapy Group for Sol...

Oct 3, 2023

STAT+: NIH halts funding for Colombian research facilities accused of abusing animals

STAT+: NIH halts funding for Colombian research facilit...

Jul 6, 2023

STAT+: FDA removes neurologist with financial ties to Eisai and Biogen from Alzheimer’s advisory panel

STAT+: FDA removes neurologist with financial ties to E...

Jun 6, 2023